The latest research from Fore Pharma, Europe Melanoma Market and Competitive Landscape – 2020, provides comprehensive insights into Melanoma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Melanoma market size and drug sales. It also provides insights into Melanoma epidemiology and late stage pipeline.
This research covers the following – Melanoma treatment options, Melanoma late stage clinical trials pipeline, Melanoma prevalence by countries, Melanoma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).
Research Scope:
– Countries: Germany, France, Italy, Spain, UK, Europe
– Melanoma pipeline: Find out drugs in clinical trials for Melanoma by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Melanoma epidemiology: Find out number of patients diagnosed (prevalence) with Melanoma by countries
– Melanoma drugs: Identify key drugs marketed and prescribed for Melanoma by countries, including trade name, molecule name, and company
– Melanoma drugs sales: Find out the sales value for Melanoma drugs by countries
– Melanoma market valuations: Find out the market size for Melanoma drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Melanoma drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Melanoma drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Melanoma market
– Develop in-depth knowledge of competition and markets
– Analyze Melanoma drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Melanoma market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Melanoma Treatment Options
2. Melanoma Pipeline Insights
2.1. Melanoma Phase 3 Clinical Trials
2.2. Melanoma Phase 2 Clinical Trials
2.3. Melanoma Phase 1 Clinical Trials
3. Melanoma Epidemiology Analysis by Countries
4. Germany Melanoma Market Insights
4.1. Marketed Drugs for Melanoma in Germany
4.2. Germany Melanoma Market Size & Forecast
4.3. Germany Melanoma Drugs Sales Forecast
4.4. Germany Melanoma Market Share Analysis
5. France Melanoma Market Insights
5.1. Marketed Drugs for Melanoma in France
5.2. France Melanoma Market Size & Forecast
5.3. France Melanoma Product Sales Forecast
5.4. France Melanoma Market Share Analysis
6. Italy Melanoma Market Insights
6.1. Marketed Drugs for Melanoma in Italy
6.2. Italy Melanoma Market Size & Forecast
6.3. Italy Melanoma Product Sales Forecast
6.4. Italy Melanoma Market Share Analysis
7. Spain Melanoma Market Insights
7.1. Marketed Drugs for Melanoma in Spain
7.2. Spain Melanoma Market Size & Forecast
7.3. Spain Melanoma Product Sales Forecast
7.4. Spain Melanoma Market Share Analysis
8. UK Melanoma Market Insights
8.1. Marketed Drugs for Melanoma in UK
8.2. UK Melanoma Market Size & Forecast
8.3. UK Melanoma Product Sales Forecast
8.4. UK Melanoma Market Share Analysis
9. Europe Melanoma Market Insights
9.1. Europe Melanoma Market Size & Forecast
9.2. Europe Melanoma Product Sales Forecast
9.3. Europe Melanoma Market Share Analysis
10. Research Methodology
List of Tables
1: Melanoma Phase 3 Clinical Trials, Global, 2020
2: Melanoma Phase 2 Clinical Trials, Global, 2020
3: Melanoma Phase 1 Clinical Trials, Global, 2020
4: Melanoma Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Melanoma in Germany, 2019
6: Germany Melanoma Market Size & Forecast ($mn), 2016 – 2025
7: Germany Melanoma Product Sales ($mn), 2016 – 2025
8: Germany Melanoma Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Melanoma in France, 2019
10: France Melanoma Market Size & Forecast ($mn), 2016 – 2025
11: France Melanoma Product Sales ($mn), 2016 – 2025
12: France Melanoma Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Melanoma in Italy, 2019
14: Italy Melanoma Market Size & Forecast ($mn), 2016 – 2025
15: Italy Melanoma Product Sales ($mn), 2016 – 2025
16: Italy Melanoma Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Melanoma in Spain, 2019
18: Spain Melanoma Market Size & Forecast ($mn), 2016 – 2025
19: Spain Melanoma Product Sales ($mn), 2016 – 2025
20: Spain Melanoma Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Melanoma in UK, 2019
22: UK Melanoma Market Size & Forecast ($mn), 2016 – 2025
23: UK Melanoma Product Sales ($mn), 2016 – 2025
24: UK Melanoma Market Events and Trends, 2016 – 2025
25: Europe Melanoma Market Size & Forecast ($mn), 2016 – 2025
26: Europe Melanoma Product Sales ($mn), 2016 – 2025
List of Figures
1: Melanoma Pipeline by Phase (%), Global, 2020
2: Melanoma Prevalence by Countries, 2016 – 2025
3: Germany Melanoma Market Size ($mn), 2016 – 2025
4: Germany Melanoma Product Sales ($mn), 2016 – 2025
5: Germany Melanoma Market Share by Drugs (%), 2019
6: Germany Melanoma Market – Future Market Share (%), 2025
7: France Melanoma Market Size ($mn), 2016 – 2025
8: France Melanoma Product Sales ($mn), 2016 – 2025
9: France Melanoma Market Share by Drugs (%), 2019
10: France Melanoma Market – Future Market Share (%), 2025
11: Italy Melanoma Market Size ($mn), 2016 – 2025
12: Italy Melanoma Product Sales ($mn), 2016 – 2025
13: Italy Melanoma Market Share by Drugs (%), 2019
14: Italy Melanoma Market – Future Market Share (%), 2025
15: Spain Melanoma Market Size ($mn), 2016 – 2025
16: Spain Melanoma Product Sales ($mn), 2016 – 2025
17: Spain Melanoma Market Share by Drugs (%), 2019
18: Spain Melanoma Market – Future Market Share (%), 2025
19: UK Melanoma Market Size ($mn), 2016 – 2025
20: UK Melanoma Product Sales ($mn), 2016 – 2025
21: UK Melanoma Market Share by Drugs (%), 2019
22: UK Melanoma Market – Future Market Share (%), 2025
23: Europe Melanoma Market Size ($mn), 2016 – 2025
24: Europe Melanoma Product Sales ($mn), 2016 – 2025
25: Europe Melanoma Market Share by Drugs (%), 2019
26: Europe Melanoma Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.